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cagA and cagE present cagI and cagT introduced cagII part
in cagPAI.
In this study we consider to genetic characteristics of the
cagI and cagII regions in cagPAI and its signiﬁcance in the
Iranian strains of H. pylori isolated from peptic ulcer (PUD)
and non ulcer disease (NUD) patients.
Methods: Clinical isolates of H. pylori were collected
from 120 patients with gastric disorders that 80 gastric
biopsies were qualiﬁed for next steps. These samples were
cultured for H. pylori by conventional methods. The genomic
DNA was extracted from biopsy samples by QIAgen kit. The
PCR was performed for detection of cagA, cagE and cagT in
cag PAI.
Results: The positive rates of 80 H. pylori strains, 20 (25%)
and 60 (75%) were PUD and NUD patients respectively. In
PUD patients with rate of 14 (70%), all of isolates were cagA
- positive and distribution of cagE and cagT were7 (35%) and
5 (25%) in these patients. On the other hand the prevalence
of cagA, cagE and cagT in NUD patients were 48 (80%), 21
(35%) and 22 (36%) respectively. Co-existence of cagT/cagE,
cagT/cagA and cagA/cagE were 5, 6 and 7 in PUD patients.
Conclusion: The structural variety of the cag PAI might be
related to the virulence of H. pylori. Our results showed the
prevalence of cagT in PUD patients is less than NUD while,
in dyspepsia patients it is more associated with cagA until
cagE, it can be for important role of cagA in peptic ulcer
disease. Also with attention to cagT as a marker for cagII
and cagA and E for cagI we can conclude the presence of
both parts of cag PAI is not need for producing of ulcer in
patients necessarily.
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Background and Aim: Previous studies showed the
increased prevalence of new onset of irritable bowel syn-
drome (IBS) after acute gastroenteritis. Associated risk
factors with this condition in hospitalized patients were not
well deﬁned. We aimed to investigate the prevalence of
post-infective IBS (PI-IBS) in hospitalized patients after a
bacteriologically conﬁrmed acute bacterial gastroenteritis
and associated risk factors with this condition.
Patients and Methods: Medical records of 112 patients
were evaluated (mean) 8 months after the acute infection.
Presence of IBS and its clinical subtypes according to the
Rome II criteria and anxiety score according to Beck’s anx-
iety scale for each subject, before and after the infection,
were evaluated by telephone interview method. Statistical
Analysis: Features of groups were compared with each other
by t-test and chi-square.
Results: Of the 90 patients, 53% were females. The preva-
lence of PI-IBS was higher than the previous IBS rate in this
group (17.8 vs 7.8%, respectively; p < 0.01). The prevalence
of PI-IBS was 14.2% in themen vs. 35.4% in females (p < 0.05).
Anxyte has been detected in 37.5% of the subjects with PI-IBS
vs. in 9.5% of the subjects without PI-IBS (p < 0.01). Subjects
with PI-IBS were more common in younger age (p < 0.05 for
each).
Conclusions: Host factors (age, gender and psychological
proﬁle) are strong players in the pathogenesis of PI-IBS.
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Aspiration pneumonia (AP) and primary lung abscess(PA)
are important complications following aspiration of infec-
tious material from the oropharynx or stomach;fatality rates
of up to 20% have been reported.1 The principal therapeu-
tic strategy is a prolonged course of antibiotiv therapy after
exclusion of bronchial obstruction.-
In two prospective studies between 1995 and 2005
a total of 234 patients with these infections were
investigated.2,3 Ampicillin/sulbactam (AS) was compared to
clindamycin/CL) plus a cephalosporin in the ﬁrst study and
to moxiﬂoxacin(MX)in the second study. 166 patients (mean
age 60, 5 years, 72% males) were treated according to
the protocol;85 pat. received AS in an i.v. starting dosis
of 3.0 g three times daily followed by twice daily 750mg
orally.Leading pathogens collected by bronchoscopy were
S.aureus, Klebs.pneum. and anaerobes.Overall clinicalre-
sponse rate at end of therapy was 69, 8% for AS, 66, 7%
for CL and 66, 7% for MX. Mean duration of treatment was
between 22± 23 days for AS and 26± 29 days for MX. All
three antibiotic regimes were well tolerated.
Conclusions: Ampicillin/sulbactam proved equally
effective and safe as comparators (clindamycin plus
cephalosporin or moxiﬂoxacin) in the treatment of
aspiration pneumonia and primary lung abscess.
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